Function and mechanism of cancer-testis antigen CT63 in chronic myeloid leukemia

Objective·To explore the effects of the cancer-testis antigen (CTA) family member CT63 on proliferation, differentiation, and tumorigenicity of chronic myeloid leukemia (CML) cells, and uncover the underlying molecular mechanisms.Methods·The link between CT63 expression and the prognosis of myeloid...

Full description

Bibliographic Details
Published in:	Shanghai Jiaotong Daxue xuebao. Yixue ban
Main Authors:	KONG Ruxin, ZHOU Yaqun, WEI Tingyi, LEI Ming
Format:	Article
Language:	Chinese
Published:	Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science) 2024-11-01
Subjects:	cancer-testis antigen 63 chronic myeloid leukemia cell proliferation cell differentiation mitochondria
Online Access:	https://xuebao.shsmu.edu.cn/article/2024/1674-8115/1674-8115-2024-44-11-1347.shtml

Similar Items

Regulation of Tetraspanin CD63 in Chronic Myeloid Leukemia (CML): Single-Cell Analysis of Asymmetric Hematopoietic Stem Cell Division Genes
by: Christophe Desterke, et al.
Published: (2025-07-01)

Chimeric antigen receptor T-cell therapy in the treatment of acute myeloid leukemia: Possible challenges
by: Rahul Jagdishchandra Mittal, et al.
Published: (2021-01-01)

Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations
by: Beatriz Guijarro-Albaladejo, et al.
Published: (2024-04-01)

Promotive effect of cancer-testis antigen CT57 on proliferation, invasion, migration and epithelial-mesenchymal transition of liver cancer cells
by: LUO Lange, et al.
Published: (2024-11-01)

Recent advances of chimeric antigen receptor T‐cell therapy for acute myeloid leukemia
by: Yang Liu, et al.
Published: (2025-05-01)

Co-expression of tumor suppressor p53 (TP53) and cancer testis antigens (CTAs) as the possible indicator of “cancer-free” status
by: D. Marjanidze, et al.
Published: (2023-01-01)

Uncovering a new cellular origin for acute myeloid leukemia with lineage plasticity
by: Melinda Czeh, et al.
Published: (2017-03-01)

Exploring the mechanism of fraxetin against acute myeloid leukemia through cell experiments and network pharmacology
by: Tingting Fang, et al.
Published: (2024-06-01)

PHF6 loss reduces leukemia stem cell activity in an acute myeloid leukemia mouse model
by: Shengnan Yuan, et al.
Published: (2024-02-01)

Acute myeloid leukemia-derived bone marrow mesenchymal cells exhibit improved support for leukemic cell proliferation
by: Mariane Cristina do Nascimento, et al.
Published: (2024-12-01)

Renal Cell Carcinoma: A Cancer-testis Antigen Poor Malignancy
by: Sepideh Faramarzi, et al.
Published: (2017-09-01)

Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer
by: Dawn Sijin Nin, et al.
Published: (2023-03-01)

Targeting PRAME for acute myeloid leukemia therapy
by: Jinjun Yang, et al.
Published: (2024-03-01)

CANCER TESTIS ANTIGENS IN CANCER IMMUNOTHERAPY
by: D. I. Vodolazhsky, et al.
Published: (2017-06-01)

Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia
by: Elissa Tjahjono, et al.
Published: (2025-01-01)

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
by: Karina Barbosa, et al.
Published: (2023-08-01)

Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and Tribulations
by: Swati Garg, et al.
Published: (2023-11-01)

Is Flow Cytometric Immunophenotyping Useful for Predicting Acute Myeloid Leukemia Prognosis?
by: Hava Üsküdar Teke, et al.
Published: (2017-12-01)

NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia
by: Qing Zhu, et al.
Published: (2025-12-01)

The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
by: Lin Chen, et al.
Published: (2013-02-01)

Immunosuppressive cells in acute myeloid leukemia: mechanisms and therapeutic target
by: Mengnan Liu, et al.
Published: (2025-07-01)

Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion
by: Phatchanat Klaihmon, et al.
Published: (2024-07-01)

Advancing Chimeric Antigen Receptor T-Cell Therapy for Acute Myeloid Leukemia: Current Limitations and Emerging Strategies
by: Daniela Damiani, et al.
Published: (2024-12-01)

Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia
by: Mariarita Spampinato, et al.
Published: (2024-07-01)

Iron overload promotes myeloid differentiation of normal hematopoietic stem cells and educates macrophage mediated immunosuppression in acute myeloid leukemia
by: Feifei Yang, et al.
Published: (2025-08-01)

Human leukocyte antigen-B27: The genetic predisposition leading to reactive arthritis during induction phase chemotherapy for acute myeloid leukemia
by: Sandip P Bartakke, et al.
Published: (2017-01-01)

CDA gene silencing regulated the proliferation and apoptosis of chronic myeloid leukemia K562 cells
by: Xiao-Fang Wei, et al.
Published: (2018-07-01)

Research status and advances in immunotherapy for chronic myeloid leukemia
by: WANG Mengmeng, et al.
Published: (2025-05-01)

Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia
by: Tomislav Smoljo, et al.
Published: (2023-10-01)

CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia
by: Xuanqi Cao, et al.
Published: (2022-09-01)

What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias
by: Marco Pizzi, et al.
Published: (2023-03-01)

Prediction and identification of HLA-A*0201-restricted epitopes from cancer testis antigen CT23
by: Xia Zeng, et al.
Published: (2023-12-01)

Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in glioma
by: Shenghua Zhuo, et al.
Published: (2024-10-01)

Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer
by: Ramilia Vlasenkova, et al.
Published: (2023-09-01)

Chimeric antigen receptor‐engineered adoptive cell therapy for AML: Current status and future perspectives
by: Yue Huang, et al.
Published: (2022-06-01)

Overexpression of MYCT1 Inhibits Proliferation and Induces Apoptosis in Human Acute Myeloid Leukemia HL-60 and KG-1a Cells in vitro and in vivo
by: Shuang Fu, et al.
Published: (2018-09-01)

Overcoming Antigen Escape and T-Cell Exhaustion in CAR-T Therapy for Leukemia
by: Elżbieta Bartoszewska, et al.
Published: (2024-09-01)

Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia
by: Christopher Schorr, et al.
Published: (2022-12-01)

Methylation Profile of Cancer Testis Antigens in Colorectal Cancer
by: Nadiah Abu, et al.
Published: (2023-03-01)

Stability and Bifurcation of the Immune Model of Chronic Myeloid Leukemia with Time Delay
by: WANG Jingnan, et al.
Published: (2024-10-01)